๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI ยท Real-Time Price ยท USD
1.580
+0.026 (1.67%)
At close: Nov 20, 2026, 4:00 PM EST
1.400
-0.180 (-11.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

Scinai Immunotherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.071.310.66---
Revenue Growth
144.38%99.24%----
Gross Profit
-3.71-2.65-0.58---
Operating Income
-8.47-7.54-8.64-9.71-11.06-10.86
Net Income
-2.46-8.31--6.5-5.8-8.21
Earnings Per Share
-4.62-35.58--166.39-307.45-800.00
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.711.661.964.8714.0817.37
Total Debt
3.392.272.0920.5621.5428.99
Net Cash (Debt)
-1.68-0.61-0.12-15.69-7.47-11.61
Net Cash Growth
------
Net Cash Per Share
-3.16-2.60-1.51-401.65-396.09-822.66

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.07-6.03-6.34-9.38-7.27-7.43
Capital Expenditures
-0.24-0.02-0.01-0.64-0.84-0.14
Free Cash Flow
-7.31-6.06-6.35-10.02-8.1-7.57
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-121.09%-202.29%-88.15%---
Operating Margin
-276.10%-575.29%-1312.77%---
Pretax Margin
-80.08%-633.64%728.88%---
Profit Margin
-80.08%-633.64%----
FCF Margin
-238.18%-461.86%-964.59%---

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.171.884.34---